3 Beaten-Down Stocks That Could Double Your Money_老虎社区_美港股上老虎

3 Beaten-Down Stocks That Could Double Your Money

Motley Fool2021-04-02

Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

883

tearach
·2021-04-05
2o
回复
点赞
举报
och
·2021-04-05
Like and comment pls, thx! [微笑]
回复
2
举报
收起
- tearach:
  ok
  2021-04-05
  回复
  举报
chahcx
·2021-04-05
Please like and comment
回复
1
举报
收起
- och:
  [开心]
  2021-04-05
  回复
  举报
MoneyCum
·2021-04-05
Lol
回复
2
举报
收起
- chahcx:
  pls comment back beheh
  2021-04-05
  回复
  举报
JaNice
·2021-04-05
Good read
回复
4
举报
收起
- Deont:
  Good
  2021-04-05
  回复
  举报
- chahcx:
  pls comment back hahah
  2021-04-05
  回复
  举报
- JaNice:
  Yea
  2021-04-05
  回复
  举报
查看更多 1 条评论
TANJLM
·2021-04-05
Please like my comment
回复
4
举报
收起
- schsch:
  ok done
  2021-04-05
  回复
  举报
PickaChew
·2021-04-05
Comment and like pls
回复
1
举报
收起
- BLMJ:
  Ok
  2021-04-05
  回复
  举报
Kok
·2021-04-05
Ok
回复
1
举报
ItsRileyReid
·2021-04-05
Nice
回复
1
举报
Ddazes
·2021-04-05
Nice
回复
4
举报
收起
- CL777:
  [财迷]
  2021-04-07
  回复
  举报
43c0b98
·2021-04-05
I love all of u tiger traders. Do u love me???
回复
2
举报
收起
- Kok:
  love
  2021-04-05
  回复
  举报
LongZR
·2021-04-05
Nice
回复
点赞
举报
收起
- 43c0b98:
  i love u
  2021-04-05
  回复
  举报
Qaal
·2021-04-05
Ok
回复
点赞
举报
收起
- 43c0b98:
  i love u
  2021-04-05
  回复
  举报
ZY91
·2021-04-05
Like and comment pls!
回复
2
举报
收起
- rsaje:
  Done
  2021-04-05
  回复
  举报
- ZY91:
  Thanks!
  2021-04-05
  回复
  举报
Ironteam
·2021-04-05
Potential stocks to research
回复
1
举报
理财的孩子
·2021-04-05
Ok
回复
3
举报
收起
- Angsana:
  huat
  2021-04-05
  回复
  举报
- TemasekHodl:
  Yes
  2021-04-05
  回复
  举报
- 理财的孩子:
  Coins ya
  2021-04-05
  回复
  举报
查看更多 2 条评论
ThaigerB
·2021-04-05
Like and comment tkns
回复
4
举报
收起
- 理财的孩子:
  Ok
  2021-04-05
  回复
  举报
- cheekeong:
  Like n comments. Thx
  2021-04-05
  回复
  举报
SSVC
·2021-04-05
Cool Appreciate your response and comments Thanks
回复
3
举报
收起
- awbeans:
  Good to monitor n buy when they r low
  2021-04-05
  回复
  举报
- SSVC:
  [强][握手]
  2021-04-05
  回复
  举报
- 理财的孩子回复SSVC:
  Ok
  2021-04-05
  回复
  举报
Coolboy750
·2021-04-05
Like and comment pls
回复
3
举报
收起
- KingWQ:
  comment back pls
  2021-04-05
  回复
  举报
- ShenSiang:
  Comment back
  2021-04-05
  回复
  举报
- KingWQ回复ShenSiang:
  thanks
  2021-04-05
  回复
  举报
francis3
·2021-04-05
May buy some numbers in these stocks
回复
4
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-04-02 20:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188150614","market":"us","top_or_hot":-1,"title":"3 Beaten-Down Stocks That Could Double Your Money","media":"Motley Fool","content":"<div>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far...\n\n<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-02 20:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/>Motley Fool</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far...\n\n<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","article_id":"1188150614","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","pubTimestamp":1617366389,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"3只能让你的钱翻倍的跌停股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":349669521,"gmtCreate":1617605835863,"gmtModify":1634297631846,"author":{"id":"3575256032463698","authorId":"3575256032463698","name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3575256032463698","idStr":"3575256032463698"},"htmlText":"2o","listText":"2o","text":"2o","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349669521","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":349680866,"gmtCreate":1617603713555,"gmtModify":1634297640940,"author":{"id":"3565663543754207","authorId":"3565663543754207","name":"och","avatar":"https://static.tigerbbs.com/1c195b2a32a90ae2210984600e352644","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3565663543754207","idStr":"3565663543754207"},"htmlText":"Like and comment pls, thx!&nbsp;[微笑]&nbsp;","listText":"Like and comment pls, thx!&nbsp;[微笑]&nbsp;","text":"Like and comment pls, thx! [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349680866","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960824,"gmtCreate":1617605848398,"gmtModify":1635743926602,"authorId":3575256032463698,"author":{"id":3575256032463698,"idStr":"3575256032463698","authorId":3575256032463698,"name":"tearach","avatar":"https://static.tigerbbs.com/861adeae93387d8335f9550889bafb00","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349680866,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":349614071,"gmtCreate":1617603320093,"gmtModify":1634297642662,"author":{"id":"3577935469270315","authorId":"3577935469270315","name":"chahcx","avatar":"https://static.tigerbbs.com/2fec84ea15dbb88ff2a986853bbb3fcc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3577935469270315","idStr":"3577935469270315"},"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349614071","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960699,"gmtCreate":1617603739760,"gmtModify":1635743936506,"authorId":3565663543754207,"author":{"id":3565663543754207,"idStr":"3565663543754207","authorId":3565663543754207,"name":"och","avatar":"https://static.tigerbbs.com/1c195b2a32a90ae2210984600e352644","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349614071,"type":1,"supId":0,"prevId":0,"content":"[开心]","text":"[开心]","html":"[开心]"}],"langContent":"EN"},{"id":349634801,"gmtCreate":1617601000703,"gmtModify":1634297651690,"author":{"id":"3575437443107611","authorId":"3575437443107611","name":"MoneyCum","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3575437443107611","idStr":"3575437443107611"},"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349634801","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960678,"gmtCreate":1617603343812,"gmtModify":1635743938254,"authorId":3577935469270315,"author":{"id":3577935469270315,"idStr":"3577935469270315","authorId":3577935469270315,"name":"chahcx","avatar":"https://static.tigerbbs.com/2fec84ea15dbb88ff2a986853bbb3fcc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349634801,"type":1,"supId":0,"prevId":0,"content":"pls comment back beheh","text":"pls comment back beheh","html":"pls comment back beheh"}],"langContent":"EN"},{"id":349638466,"gmtCreate":1617600136955,"gmtModify":1634297654696,"author":{"id":"3574939383328580","authorId":"3574939383328580","name":"JaNice","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3574939383328580","idStr":"3574939383328580"},"htmlText":"Good read","listText":"Good read","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/349638466","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960569,"gmtCreate":1617601273323,"gmtModify":1635743947647,"authorId":3572949737859102,"author":{"id":3572949737859102,"idStr":"3572949737859102","authorId":3572949737859102,"name":"Deont","avatar":"https://static.tigerbbs.com/b69cb3aef6e3479f1dd8cb3e0eda4f60","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349638466,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":3960675,"gmtCreate":1617603332956,"gmtModify":1635743938472,"authorId":3577935469270315,"author":{"id":3577935469270315,"idStr":"3577935469270315","authorId":3577935469270315,"name":"chahcx","avatar":"https://static.tigerbbs.com/2fec84ea15dbb88ff2a986853bbb3fcc","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349638466,"type":1,"supId":0,"prevId":0,"content":"pls comment back hahah","text":"pls comment back hahah","html":"pls comment back hahah"},{"id":3960765,"gmtCreate":1617604898503,"gmtModify":1635743931523,"authorId":3574939383328580,"author":{"id":3574939383328580,"idStr":"3574939383328580","authorId":3574939383328580,"name":"JaNice","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349638466,"type":1,"supId":3960569,"prevId":0,"content":"Yea","text":"Yea","html":"Yea"},{"id":3960766,"gmtCreate":1617604904188,"gmtModify":1635743931413,"authorId":3574939383328580,"author":{"id":3574939383328580,"idStr":"3574939383328580","authorId":3574939383328580,"name":"JaNice","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349638466,"type":1,"supId":3960675,"prevId":0,"content":"Ok done!","text":"Ok done!","html":"Ok done!"}],"langContent":"EN"},{"id":349695347,"gmtCreate":1617598684089,"gmtModify":1634297660888,"author":{"id":"3578653477505914","authorId":"3578653477505914","name":"TANJLM","avatar":"https://static.tigerbbs.com/677d3f685323d4c95503735c11f8d5a5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578653477505914","idStr":"3578653477505914"},"htmlText":"Please like my comment","listText":"Please like my comment","text":"Please like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349695347","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960485,"gmtCreate":1617599728840,"gmtModify":1635743953986,"authorId":3575927670533252,"author":{"id":3575927670533252,"idStr":"3575927670533252","authorId":3575927670533252,"name":"schsch","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349695347,"type":1,"supId":0,"prevId":0,"content":"ok done","text":"ok done","html":"ok done"}],"langContent":"EN"},{"id":349604268,"gmtCreate":1617597133454,"gmtModify":1634297667960,"author":{"id":"3575623648551699","authorId":"3575623648551699","name":"PickaChew","avatar":"https://static.tigerbbs.com/e64125a635ce42e8dfd601284ad29438","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3575623648551699","idStr":"3575623648551699"},"htmlText":"Comment and like pls","listText":"Comment and like pls","text":"Comment and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349604268","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960308,"gmtCreate":1617597362394,"gmtModify":1635743968941,"authorId":3554847571879592,"author":{"id":3554847571879592,"idStr":"3554847571879592","authorId":3554847571879592,"name":"BLMJ","avatar":"https://static.tigerbbs.com/9944d8556a10ec8933033bf4a3d557b5","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349604268,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":349601411,"gmtCreate":1617596369733,"gmtModify":1634297671203,"author":{"id":"3560204717545571","authorId":"3560204717545571","name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3560204717545571","idStr":"3560204717545571"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349601411","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":349876261,"gmtCreate":1617595057653,"gmtModify":1634297678493,"author":{"id":"3575184455730384","authorId":"3575184455730384","name":"ItsRileyReid","avatar":"https://static.tigerbbs.com/2104a50c539eebad8cbb8bb664fa8232","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3575184455730384","idStr":"3575184455730384"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349876261","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":349876365,"gmtCreate":1617595040257,"gmtModify":1634297678953,"author":{"id":"3570925230110099","authorId":"3570925230110099","name":"Ddazes","avatar":"https://static.tigerbbs.com/6ba801dfb90539ab362f1d1efe8729c7","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570925230110099","idStr":"3570925230110099"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349876365","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3974344,"gmtCreate":1617754482710,"gmtModify":1635743029018,"authorId":3560241002253187,"author":{"id":3560241002253187,"idStr":"3560241002253187","authorId":3560241002253187,"name":"CL777","avatar":"https://static.tigerbbs.com/e9aef3dd830373a0427a3447b1b564e3","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349876365,"type":1,"supId":0,"prevId":0,"content":"[财迷]","text":"[财迷]","html":"[财迷]"}],"langContent":"EN"},{"id":349871441,"gmtCreate":1617594847983,"gmtModify":1634297680237,"author":{"id":"3576232257279797","authorId":"3576232257279797","name":"43c0b98","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576232257279797","idStr":"3576232257279797"},"htmlText":"I love all of u tiger traders. Do u love me???","listText":"I love all of u tiger traders. Do u love me???","text":"I love all of u tiger traders. Do u love me???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349871441","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960256,"gmtCreate":1617596383179,"gmtModify":1635743973508,"authorId":3560204717545571,"author":{"id":3560204717545571,"idStr":"3560204717545571","authorId":3560204717545571,"name":"Kok","avatar":"https://static.tigerbbs.com/efc25bb5380f85af49509ed68d9a3d8f","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349871441,"type":1,"supId":0,"prevId":0,"content":"love","text":"love","html":"love"}],"langContent":"EN"},{"id":349844232,"gmtCreate":1617593734226,"gmtModify":1634297685140,"author":{"id":"3572305441240915","authorId":"3572305441240915","name":"LongZR","avatar":"https://static.tigerbbs.com/80b6c7bb6866455f69d500fddb520c7e","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3572305441240915","idStr":"3572305441240915"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349844232","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960149,"gmtCreate":1617594860118,"gmtModify":1635743981862,"authorId":3576232257279797,"author":{"id":3576232257279797,"idStr":"3576232257279797","authorId":3576232257279797,"name":"43c0b98","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349844232,"type":1,"supId":0,"prevId":0,"content":"i love u","text":"i love u","html":"i love u"}],"langContent":"EN"},{"id":349846782,"gmtCreate":1617593311846,"gmtModify":1634297687707,"author":{"id":"3577432645863048","authorId":"3577432645863048","name":"Qaal","avatar":"https://static.tigerbbs.com/0ebae6fa58e32daca8a545858cb2b589","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3577432645863048","idStr":"3577432645863048"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/349846782","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960154,"gmtCreate":1617594892014,"gmtModify":1635743981317,"authorId":3576232257279797,"author":{"id":3576232257279797,"idStr":"3576232257279797","authorId":3576232257279797,"name":"43c0b98","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349846782,"type":1,"supId":0,"prevId":0,"content":"i love u","text":"i love u","html":"i love u"}],"langContent":"EN"},{"id":349843335,"gmtCreate":1617592813727,"gmtModify":1634297690093,"author":{"id":"3562676573275376","authorId":"3562676573275376","name":"ZY91","avatar":"https://static.tigerbbs.com/6d50f122ab4e33216acfea13d1173f47","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3562676573275376","idStr":"3562676573275376"},"htmlText":"Like and comment pls!&nbsp;","listText":"Like and comment pls!&nbsp;","text":"Like and comment pls!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/349843335","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3960240,"gmtCreate":1617596177832,"gmtModify":1635743974698,"authorId":3579596992743233,"author":{"id":3579596992743233,"idStr":"3579596992743233","authorId":3579596992743233,"name":"rsaje","avatar":"https://static.tigerbbs.com/0a2a15d8b3af15a33dda43a5e023aa8f","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349843335,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":3960930,"gmtCreate":1617607627024,"gmtModify":1635743919436,"authorId":3562676573275376,"author":{"id":3562676573275376,"idStr":"3562676573275376","authorId":3562676573275376,"name":"ZY91","avatar":"https://static.tigerbbs.com/6d50f122ab4e33216acfea13d1173f47","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349843335,"type":1,"supId":3960240,"prevId":0,"content":"Thanks!","text":"Thanks!","html":"Thanks!"}],"langContent":"EN"},{"id":349853086,"gmtCreate":1617591386545,"gmtModify":1634297696053,"author":{"id":"3561582804451218","authorId":"3561582804451218","name":"Ironteam","avatar":"https://static.tigerbbs.com/820ff4e88bef87bdd250ce62ad08f334","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3561582804451218","idStr":"3561582804451218"},"htmlText":"Potential stocks to research","listText":"Potential stocks to research","text":"Potential stocks to research","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349853086","repostId":1188150614,"repostType":2,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":349826262,"gmtCreate":1617590464656,"gmtModify":1634297700845,"author":{"id":"3555464381271027","authorId":"3555464381271027","name":"理财的孩子","avatar":"https://static.tigerbbs.com/93cd37a262dd5bbd44770192dd5619cd","vip":1,"crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3555464381271027","idStr":"3555464381271027"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/349826262","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3959872,"gmtCreate":1617591536877,"gmtModify":1635744001204,"authorId":3575326435298567,"author":{"id":3575326435298567,"idStr":"3575326435298567","authorId":3575326435298567,"name":"Angsana","avatar":"https://static.tigerbbs.com/3c8492153d7059ec1aa704a1bd541c14","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826262,"type":1,"supId":0,"prevId":0,"content":"huat","text":"huat","html":"huat"},{"id":3959890,"gmtCreate":1617591771062,"gmtModify":1635743999787,"authorId":3575875627318890,"author":{"id":3575875627318890,"idStr":"3575875627318890","authorId":3575875627318890,"name":"TemasekHodl","avatar":"https://static.tigerbbs.com/daf0f0cedc45f1f983d55640fafb8b6d","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826262,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"},{"id":3959934,"gmtCreate":1617592195737,"gmtModify":1635743998364,"authorId":3555464381271027,"author":{"id":3555464381271027,"idStr":"3555464381271027","authorId":3555464381271027,"name":"理财的孩子","avatar":"https://static.tigerbbs.com/93cd37a262dd5bbd44770192dd5619cd","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826262,"type":1,"supId":3959890,"prevId":0,"content":"Coins ya","text":"Coins ya","html":"Coins ya"},{"id":3959935,"gmtCreate":1617592201648,"gmtModify":1635743998252,"authorId":3555464381271027,"author":{"id":3555464381271027,"idStr":"3555464381271027","authorId":3555464381271027,"name":"理财的孩子","avatar":"https://static.tigerbbs.com/93cd37a262dd5bbd44770192dd5619cd","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826262,"type":1,"supId":3959872,"prevId":0,"content":"Same same","text":"Same same","html":"Same same"},{"id":3961945,"gmtCreate":1617618357772,"gmtModify":1635743850124,"authorId":3574906731000207,"author":{"id":3574906731000207,"idStr":"3574906731000207","authorId":3574906731000207,"name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826262,"type":1,"supId":0,"prevId":0,"content":"[强][握手]","text":"[强][握手]","html":"[强][握手]"}],"langContent":"EN"},{"id":349826075,"gmtCreate":1617590417097,"gmtModify":1634297701448,"author":{"id":"3579576204997725","authorId":"3579576204997725","name":"ThaigerB","avatar":"https://static.tigerbbs.com/8a8c11fe841ba6ed0f15e36becdaa772","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3579576204997725","idStr":"3579576204997725"},"htmlText":"Like and comment tkns","listText":"Like and comment tkns","text":"Like and comment tkns","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/349826075","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3959765,"gmtCreate":1617590475421,"gmtModify":1635744009012,"authorId":3555464381271027,"author":{"id":3555464381271027,"idStr":"3555464381271027","authorId":3555464381271027,"name":"理财的孩子","avatar":"https://static.tigerbbs.com/93cd37a262dd5bbd44770192dd5619cd","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826075,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":3959887,"gmtCreate":1617591699600,"gmtModify":1635744000114,"authorId":3569750028742479,"author":{"id":3569750028742479,"idStr":"3569750028742479","authorId":3569750028742479,"name":"cheekeong","avatar":"https://static.tigerbbs.com/064e35722748144f5c935ee80c48733c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349826075,"type":1,"supId":3959765,"prevId":0,"content":"Like n comments. Thx","text":"Like n comments. Thx","html":"Like n comments. Thx"}],"langContent":"EN"},{"id":349866686,"gmtCreate":1617589402145,"gmtModify":1634297708233,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3574906731000207","idStr":"3574906731000207"},"htmlText":"Cool Appreciate your response and comments Thanks&nbsp;","listText":"Cool Appreciate your response and comments Thanks&nbsp;","text":"Cool Appreciate your response and comments Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/349866686","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3959688,"gmtCreate":1617589628603,"gmtModify":1635744015316,"authorId":3579082829321076,"author":{"id":3579082829321076,"idStr":"3579082829321076","authorId":3579082829321076,"name":"awbeans","avatar":"https://static.tigerbbs.com/1a873a403661600fcf46de76b6b334f2","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349866686,"type":1,"supId":0,"prevId":0,"content":"Good to monitor n buy when they r low","text":"Good to monitor n buy when they r low","html":"Good to monitor n buy when they r low"},{"id":3959701,"gmtCreate":1617589796492,"gmtModify":1635744014445,"authorId":3574906731000207,"author":{"id":3574906731000207,"idStr":"3574906731000207","authorId":3574906731000207,"name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349866686,"type":1,"supId":3959688,"prevId":0,"content":"[强][握手]","text":"[强][握手]","html":"[强][握手]"},{"id":3959766,"gmtCreate":1617590481031,"gmtModify":1635744008904,"authorId":3555464381271027,"author":{"id":3555464381271027,"idStr":"3555464381271027","authorId":3555464381271027,"name":"理财的孩子","avatar":"https://static.tigerbbs.com/93cd37a262dd5bbd44770192dd5619cd","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3574906731000207,"repliedAuthor":{"id":3574906731000207,"idStr":"3574906731000207","authorId":3574906731000207,"name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":349866686,"type":1,"supId":3959688,"prevId":3959701,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":349887668,"gmtCreate":1617588713254,"gmtModify":1634297712755,"author":{"id":"3555112963364763","authorId":"3555112963364763","name":"Coolboy750","avatar":"https://static.tigerbbs.com/0be16f76d54ddf03264eca9925be4a62","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3555112963364763","idStr":"3555112963364763"},"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/349887668","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3959580,"gmtCreate":1617588892304,"gmtModify":1635744025189,"authorId":3569724209082925,"author":{"id":3569724209082925,"idStr":"3569724209082925","authorId":3569724209082925,"name":"KingWQ","avatar":"https://static.tigerbbs.com/b00b6828fef7e7f119b33b0d67188edc","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349887668,"type":1,"supId":0,"prevId":0,"content":"comment back pls","text":"comment back pls","html":"comment back pls"},{"id":3959602,"gmtCreate":1617589036207,"gmtModify":1635744023124,"authorId":3571199921041604,"author":{"id":3571199921041604,"idStr":"3571199921041604","authorId":3571199921041604,"name":"ShenSiang","avatar":"https://static.tigerbbs.com/1f4f1e93da6d6ca9664728e4cfc578bb","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":349887668,"type":1,"supId":3959580,"prevId":0,"content":"Comment back","text":"Comment back","html":"Comment back"},{"id":3963068,"gmtCreate":1617628165178,"gmtModify":1635743768105,"authorId":3569724209082925,"author":{"id":3569724209082925,"idStr":"3569724209082925","authorId":3569724209082925,"name":"KingWQ","avatar":"https://static.tigerbbs.com/b00b6828fef7e7f119b33b0d67188edc","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3571199921041604,"repliedAuthor":{"id":3571199921041604,"idStr":"3571199921041604","authorId":3571199921041604,"name":"ShenSiang","avatar":"https://static.tigerbbs.com/1f4f1e93da6d6ca9664728e4cfc578bb","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":349887668,"type":1,"supId":3959580,"prevId":3959602,"content":"thanks","text":"thanks","html":"thanks"}],"langContent":"EN"},{"id":349881212,"gmtCreate":1617588330536,"gmtModify":1634297717551,"author":{"id":"3546933005981745","authorId":"3546933005981745","name":"francis3","avatar":"https://static.tigerbbs.com/5a5e1b786e43023ae6f9a0dc560e3dd6","vip":1,"crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3546933005981745","idStr":"3546933005981745"},"htmlText":"May buy some numbers in these stocks","listText":"May buy some numbers in these stocks","text":"May buy some numbers in these stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/349881212","repostId":1188150614,"repostType":4,"repost":{"id":"1188150614","kind":"news","pubTimestamp":1617366389,"share":"https://www.laohu8.com/m/news/1188150614?lang=zh_CN&edition=full","pubTime":"2021-04-02 20:26","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188150614","media":"Motley Fool","summary":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, ho","content":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Double Your Money<blockquote>3只遭受重创的股票可以让你的钱翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMotley Fool2021-04-02 20:26\n\n</h4>\n</header>\n<article>\nMarket rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.<blockquote>市场轮动的萎靡已经感染了许多投资者。去年，成长股纳斯达克100指数指数击败了稳重的巨头道琼斯工业平均指数.不过，2021年到目前为止，情况有所不同。大笔资金似乎正在转向所谓的“避险”股票。</blockquote> As a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices.&nbsp;Here are three beaten-down stocks that could even double your money -- or more.<blockquote>结果，许多几个月前雄心勃勃的人现在都陷入了低迷。有些甚至比今年早些时候创下的峰值下降了30%以上。然而，乌云中也有一线希望：相当多具有强劲增长前景的股票可以打折购买。这里有三只遭受重创的股票，它们甚至可以让你的钱翻倍甚至更多。</blockquote> DermTech<blockquote>皮肤技术</blockquote> DermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.<blockquote>皮肤技术（纳斯达克：DMTK）推出了一款令人兴奋的产品：一种皮肤基因组学测试，可以比手术活检更准确、更便宜地检测黑色素瘤。截至2月第三周，其股价今年迄今已飙升超过145%。不过，自那以来，医疗保健股已下跌超过35%。</blockquote> Part of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.<blockquote>部分问题在于前面提到的成长型股票的普遍抛售。然而，DermTech在第四季度更新中也提供了令人失望的指引。该公司预计第一季度检测收入在160万美元至190万美元之间，而第四季度检测收入为160万美元。</blockquote> DermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.<blockquote>DermTech在接触医生方面仍然面临一些新冠肺炎的阻力。不过，该公司的长期增长前景仍然光明。DermTech继续为其首款产品色素性病变检测(PLA)获得商业付款人报销。它预计明年将推出一项家庭基因组学测试，以识别紫外线损伤和皮肤癌风险。</blockquote> The total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.<blockquote>DermTech针对所有类型皮肤癌的潜在美国市场总额约为100亿美元。由于该公司的市值目前低于15亿美元，DermTech应该只需占领这个市场的一小部分，就可以为投资者带来巨额回报。</blockquote> Gores Holdings VI<blockquote>戈尔斯控股VI</blockquote> Special purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit.&nbsp;Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.<blockquote>特殊目的收购公司（SPAC）股票不久前广受欢迎。这已经改变了很多。戈尔斯控股VI（纳斯达克股票代码：GHVI）就是一个很好的例子：截至2月中旬，SPAC的股价今年迄今飙升了120%以上，但现在较高点下跌了40%以上。</blockquote> Gores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.<blockquote>Gores Holdings VI和空间数据公司Matterport于2月8日宣布，他们计划合并，Matterport将以约29亿美元的股权价值上市。但Matterport应该能够相对较快地发展得更大。</blockquote> Matterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.<blockquote>Matterport十年前开创了空间数据市场。该公司的技术可以创建任何物理空间的3D“数字孪生”。咨询公司埃森哲最近将数字孪生技术选为2021年五大技术趋势之一。</blockquote> The company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.<blockquote>该公司已经拥有超过250,000名客户，其中包括财富1000强中的13%。然而，目前全球40多亿栋建筑中只有不到1%实现了数字化。这对Matterport来说意味着2400亿美元的机会。该公司预计2022年收入将增长近一倍，随后几年增长将加速。</blockquote> Skillz<blockquote>斯基尔茨</blockquote> Skillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.<blockquote>斯基尔茨（纽约证券交易所股票代码：SKLZ）是这三只遭受重创的股票中跌幅最大的。截至2月初，这家移动游戏平台提供商的股价飙升近120%，但随后又回吐了全部涨幅，甚至部分涨幅。今年迄今为止，该股已下跌超过5%。</blockquote> Like DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.<blockquote>与DermTech和Gores Holdings VI一样，Skillz也受到了市场远离成长型股票的负面影响。然而，该公司公开发行出售1700万股股票的决定也造成了伤害。</blockquote> Skillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.<blockquote>Skillz以竞争为中心的方法比其他领先的在线平台更能吸引用户。它也推动了巨大的增长。该公司的收入在2020年几乎翻了一番。Skillz在将用户转化为付费客户方面尤其取得了进展。</blockquote> The mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.<blockquote>去年移动游戏市场总额为860亿美元，并继续快速增长。随着Skillz在国际上扩张并在其平台上添加新类型的游戏，它应该能够增加其市场份额。该公司与NFL的多年协议也可能带来巨大推动。</blockquote> Skillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.<blockquote>Skillz看起来像是一只可以轻松让你的钱翻倍的股票，并且在未来几年内可能会带来比这更高的回报。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/\">Motley Fool</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/02/3-beaten-down-stocks-that-could-double-your-money/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188150614","content_text":"Market rotation malaise has infected many investors. Last year, the growth stocks in theNasdaq-100index trounced the staid giants in theDow Jones Industrial Average. It's been a different story so far in 2021, though. The big money appears to be moving into so-called \"risk-off\" stocks.\nAs a result, many of the high-flyers from just a few months ago are now stuck in the doldrums. Some are even down more than 30% from their peaks set earlier this year. There's a silver lining in this dark cloud, however: Quite a few stocks with strong growth prospects are available at discounted prices. Here are three beaten-down stocks that could even double your money -- or more.\nDermTech\nDermTech(NASDAQ:DMTK)markets an exciting product: a skin genomics test that can detect melanoma more accurately and cheaper than surgical biopsy. Its shares soared over 145% year to date by the third week of February. Since then, though, thehealthcare stockhas fallen more than 35%.\nPart of the problem was the aforementioned general sell-off of growth stocks. However, DermTech also provided disappointing guidance in its fourth-quarter update. The company expects first-quarter assay revenue of between $1.6 million and $1.9 million compared to Q4 assay revenue of $1.6 million.\nDermTech still faces some COVID-19 headwinds in reaching out to physicians. The company's long-term growth prospects remain bright, though. DermTech continues to pick up commercial payer reimbursement for its first product, Pigmented Lesion Assay (PLA). It expects to launch an at-home genomics test that identifies ultraviolet ray damage and skin cancer risk next year.\nThe total addressable U.S. market that DermTech is targeting for all types of skin cancer is around $10 billion. With the company's market cap currently below $1.5 billion, DermTech should only have to capture a tiny sliver of this market to deliver huge returns for investors.\nGores Holdings VI\nSpecial purpose acquisition company (SPAC) stocks were wildly popular not long ago. That's changed quite a bit. Gores Holdings VI(NASDAQ:GHVI)serves as a great example: The SPAC's shares skyrocketed more than 120% year to date by mid-February but are now down over 40% from those highs.\nGores Holdings VI and spatial data company Matterport announced on Feb. 8 that they plan to merge in a deal that will take Matterport public at an equity value of around $2.9 billion. But Matterport should be able to grow much larger than that relatively quickly.\nMatterport pioneered the spatial data market a decade ago. The company's technology can create a 3D \"digital twin\" of any physical space. Consulting firmAccenturerecently picked digital twin technology asone of its top five tech trends of 2021.\nThe company already has over 250,000 customers, including 13% of the Fortune 1000. However, less than 1% of the more than 4 billion buildings across the world are currently digitized. This represents a $240 billion opportunity for Matterport. The company expects to nearly double its revenue in 2022 with growth accelerating in subsequent years.\nSkillz\nSkillz(NYSE:SKLZ)stands as the biggest loser of these three beaten-down stocks. Shares of the mobile game platform provider soared nearly 120% by early February only to give up all of those gains and then some. The stock is now down over 5% year to date.\nLike DermTech and Gores Holdings VI, Skillz was negatively impacted by the market rotation away from growth stocks. However, the company's decision to sell 17 million shares in a public offering also hurt.\nSkillz's competition-focused approach keeps users more engaged than other leading online platforms. It's also driving tremendous growth. The company's revenue nearly doubled in 2020. Skillz is especially making inroads in converting users to paying customers.\nThe mobile gaming market totaled $86 billion last year and continues to grow rapidly. Skillz should be able to increase its market share as it expands internationally and adds new genres of games to its platform. The company's multi-year agreement with the NFL could also provide a big boost.\nSkillz looks like a stock that could easily double your money and perhaps deliver much greater returns than that over the next couple of years.","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":883,"commentSize":307,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}